A discount is a margin decision, not just a marketing decision
A discounted service can be a smart way to fill a new provider's calendar, introduce a patient to a new treatment, reward a member, or move a campaign forward. The problem starts when the practice only asks whether the offer generated bookings. Bookings and collected revenue do not say whether the product-heavy service still produced enough gross profit.
For injectables, IV therapy, GLP-1 programs, peptides, and retail-supported treatments, a discount changes the amount collected while product cost often stays the same. A provider may also use a different number of units, a newer lot may cost more, or an included add-on may increase the cost of fulfilling the visit. Those details determine whether an offer is an intentional investment or an invisible margin concession.
The right question is not whether discounts are good or bad. It is: which offers create the patient outcome and business result the practice wants while staying above a defined margin floor?
Set a margin floor before choosing the offer
A margin floor is the minimum gross margin a practice is willing to accept for a service, package, or campaign. It should be set before a promotion launches, not discovered after the team has already promised a price. The floor can vary by service because product mix, provider time, and clinical supplies vary too.
Start with the actual selling price, expected product COGS, disposables, included add-ons, and the discount value. For a unit-based injectable offer, use the cost of the specific product and a realistic estimate of units used. For an IV offer, include ingredients, supplies, and boosters. For a GLP-1 program, include medication, supplies, and any included product-related fulfillment cost.
A simple planning calculation is: collected revenue minus direct product and fulfillment cost equals gross profit; gross profit divided by collected revenue equals gross margin. It is not a complete P&L, but it is enough to stop a headline discount from masking an unworkable treatment-level offer.
Separate campaign discounts from provider discretion
A published campaign, a membership benefit, a recovery touch-up, a referral credit, and an on-the-spot provider accommodation are not the same event. When they are all recorded as a generic discount, the owner cannot tell whether margin moved because a planned promotion worked as designed or because individual exceptions accumulated.
Use clear reason codes or categories for each type of price adjustment. At a minimum, separate campaign, membership, package, referral, employee, service recovery, and provider discretion. Review both the collected revenue and the product used for each category. This gives the team a usable operating record without turning every patient interaction into a debate.
Provider discretion can be valuable, especially when it protects a long-term relationship. The goal is not to eliminate it. The goal is to make its cost visible, define reasonable guardrails, and distinguish intentional care decisions from a pricing habit that the practice has never examined.
Price the whole treatment promise, not only the headline service
Many offers look safe when evaluated as a single line item but become weak when the full promise is delivered. A toxin event may include a touch-up expectation. A filler offer may include complimentary add-ons. A weight-loss promotion may include a discount across multiple dose tiers. An IV bundle may include boosters or a follow-up visit. Each promise creates a different cost exposure.
Write the offer as the patient experiences it: eligibility, included product, allowed redemption period, add-ons, exclusions, touch-up policy, rollover or transfer rules, and whether it can stack with another discount. Then model the normal-use case and a high-use case. If the offer only works when patients underuse it, the practice should decide whether that is a relationship risk it wants to take.
This is particularly important for memberships and prepaid packages because cash arrives before the product is used. Revenue at sale is not proof of margin at redemption. Track the actual product consumption as benefits are fulfilled so future COGS does not disappear behind a successful sales month.
Use actual lot cost and actual usage in the review
A promotion should not be reviewed against a stale catalog estimate when the practice has newer inventory at a different cost. If two lots of the same injectable have different unit costs, or a newer medication shipment changed the cost per dose, the campaign economics may have changed even when the menu price did not.
Review completed discounted visits using the product actually consumed, the quantity used, the lot or batch cost where relevant, and any recorded waste. That creates a clearer distinction between a pricing issue and a usage issue. A campaign may be sound while a particular provider's usage pattern needs coaching; or usage may be stable while supplier cost made the price floor obsolete.
This level of review does not require perfect forecasting. It requires a consistent habit of replacing assumptions with the best available visit-level data before the same issue repeats across dozens of appointments.
Review promotion performance on a short, repeatable cadence
Do not wait until the end of a quarter to learn whether a promotion was profitable. A weekly review can look at booked and completed visits, collected revenue, discounts granted, product usage, exceptions, and obvious inventory pressure. A monthly review can compare gross margin by offer, provider, service, campaign source, and patient redemption pattern.
The useful decisions are concrete: keep the offer, narrow eligibility, change the included product, adjust the price, stop stacking discounts, add a minimum purchase, or turn a free add-on into a paid option. The point is not to make every offer rigid. It is to give the team a way to learn without letting a weak promotion become permanent by default.
For owner-operated practices, this cadence can be short: a recurring review of the few services and offers with the highest product cost is more useful than a sprawling report nobody reads. Start where a small price change or a few extra units can materially affect a visit's margin.
Make promotion learning part of your operating system
The strongest practices treat promotions as operational experiments, not one-off social posts. They document the offer, set a margin floor, record why discounts happen, connect product usage to the visit, and decide what to change from evidence rather than instinct.
Otzaro is built for the product-cost layer of that review: recording point-of-service COGS from the batch used, then giving owners a clearer view of margin and inventory movement. That does not replace clinical judgment or a pricing strategy. It gives those decisions a more honest cost basis.
When a practice can see both the patient-facing offer and the product cost of delivering it, it can use discounts deliberately—protecting relationships and growth without confusing more revenue with more profit.
Before a medspa launches or renews an offer, it should be able to answer
What is the minimum collected revenue that protects the treatment's gross-margin floor?
What product, supplies, add-ons, touch-ups, and redemption rules are included in the promise?
Which discounts are planned campaigns, and which are provider or service-recovery exceptions?
What did completed discounted visits actually consume by quantity and lot-level cost?
What decision will the practice make if the offer misses its margin floor?
FAQ
How should a medspa set a discount percentage?
Set a discount only after estimating the service's direct product and fulfillment cost, then choose a price that remains above the practice's gross-margin floor. The allowable percentage can vary by treatment, product cost, provider usage, and what the offer includes.
Why can a busy medspa promotion still be unprofitable?
A campaign can increase bookings and revenue while reducing gross profit if discounts, included add-ons, product usage, waste, or touch-ups are not reflected in the price. Revenue alone does not show the cost of fulfilling a product-heavy treatment.
Should providers be allowed to discount treatments?
Provider discretion can support patient relationships and service recovery. Practices should make the reason and cost visible, set clear guardrails, and review discretion separately from planned campaigns so leadership can learn where exceptions are helping or eroding margin.
How often should a practice review promotion profitability?
Review high-cost or active offers weekly for obvious exceptions and monthly for completed-visit margin, product usage, redemption behavior, and provider variation. The best cadence is frequent enough to adjust the offer before it becomes a recurring loss.